1 completed, 1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Lymphoid: new trials by email Literature Review of Lymphoid trials Research Report on Lymphoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies Fludarabine, TGFBR2 KO CAR27/IL-15 NK cells, Cyclophosphamide - Lymphoid, Hodgkin Lymphoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 60 | 2026-05-28 | 2026-09-08 |
| Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Non-Hodgkin's lymphoma (NHL) - Multiple Myeloma, Leukemia | Completed | Janssen-Cilag Ltd. | 5443 | 2014-07-01 | 2016-07-20 |
Hodgkin Disease (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Leukemia, B-Cell (1)
Cyclophosphamide (1) · fludarabine (1) · fludarabine phosphate (1) · non-Hodgkin's lymphoma protocol 8503 (1)
Janssen-Cilag Ltd. (1) · M.D. Anderson Cancer Center (1)
Argentina (1) · Brazil (1) · Chile (1) · Colombia (1) · Guatemala (1) · Mexico (1) · Panama (1) · United States (1)